9,650 Shares in Cabot Corporation $CBT Purchased by Erste Asset Management GmbH

Erste Asset Management GmbH acquired a new position in Cabot Corporation (NYSE:CBTFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 9,650 shares of the specialty chemicals company’s stock, valued at approximately $872,000.

Other hedge funds have also recently added to or reduced their stakes in the company. UBS Group AG lifted its position in shares of Cabot by 3.5% during the 4th quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock valued at $40,708,000 after acquiring an additional 20,668 shares during the period. Lazard Asset Management LLC increased its position in shares of Cabot by 96.2% in the first quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company’s stock worth $3,255,000 after purchasing an additional 21,194 shares during the period. Denali Advisors LLC bought a new position in shares of Cabot in the fourth quarter worth $5,531,000. Peregrine Capital Management LLC raised its stake in Cabot by 24.7% in the fourth quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company’s stock valued at $5,246,000 after purchasing an additional 15,669 shares in the last quarter. Finally, Norges Bank bought a new stake in Cabot during the fourth quarter worth about $49,662,000. Institutional investors own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

CBT has been the topic of a number of analyst reports. Mizuho increased their price objective on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Finally, UBS Group cut their target price on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot currently has a consensus rating of “Hold” and an average price target of $89.00.

Read Our Latest Research Report on CBT

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.08% of the company’s stock.

Cabot Stock Performance

NYSE CBT opened at $86.28 on Friday. The firm’s fifty day moving average price is $87.98 and its two-hundred day moving average price is $80.34. The stock has a market cap of $4.45 billion, a PE ratio of 24.30, a PEG ratio of 11.26 and a beta of 0.84. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. During the same period in the prior year, the company earned $1.90 EPS. Cabot’s revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities analysts expect that Cabot Corporation will post 6.33 EPS for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.2%. Cabot’s dividend payout ratio (DPR) is currently 53.24%.

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Recommended Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.